Home
>
National Drug Code (NDC)
>
DYAZIDE
DYAZIDE - 0007-3650-30 - (hydrochlorothiazide and triamterene)
Drug Information of DYAZIDE
| Product NDC: | 0007-3650 |
| Proprietary Name: | DYAZIDE |
| Non Proprietary Name: | hydrochlorothiazide and triamterene |
| Active Ingredient(s): | 25; 37.5 mg/1; mg/1 & nbsp; hydrochlorothiazide and triamterene |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DYAZIDE
| Product NDC: | 0007-3650 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016042 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19940330 |
Package Information of DYAZIDE
| Package NDC: | 0007-3650-30 |
| Package Description: | 1000 CAPSULE in 1 BOTTLE (0007-3650-30) |
NDC Information of DYAZIDE
| NDC Code | 0007-3650-30 |
| Proprietary Name | DYAZIDE |
| Package Description | 1000 CAPSULE in 1 BOTTLE (0007-3650-30) |
| Product NDC | 0007-3650 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | hydrochlorothiazide and triamterene |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19940330 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| Strength Number | 25; 37.5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
